OptimizeRx Corp Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OptimizeRx Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OptimizeRx Corp for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.75 | 1,000 | 750 | 28,000 | 27 K to 28 K (+3.70 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.74 | 2,000 | 1,480 | 27,000 | 25 K to 27 K (+8.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 1,000 | 810 | 25,000 | 24 K to 25 K (+4.17 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 1,000 | 810 | 24,000 | 23 K to 24 K (+4.35 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 2,000 | 1,620 | 23,000 | 21 K to 23 K (+9.52 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.80 | 1,000 | 800 | 21,000 | 20 K to 21 K (+5.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 1,000 | 810 | 20,000 | 19 K to 20 K (+5.26 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 1,000 | 810 | 19,000 | 18 K to 19 K (+5.56 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.82 | 2,000 | 1,640 | 18,000 | 16 K to 18 K (+12.50 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.85 | 1,000 | 850 | 16,000 | 15 K to 16 K (+6.67 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 2,000 | 1,620 | 15,000 | 13 K to 15 K (+15.38 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.81 | 1,000 | 810 | 13,000 | 12 K to 13 K (+8.33 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.85 | 1,000 | 850 | 12,000 | 11 K to 12 K (+9.09 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.70 | 1,000 | 700 | 11,000 | 10 K to 11 K (+10.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.71 | 1,000 | 710 | 10,000 | 9 K to 10 K (+11.11 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.75 | 1,000 | 750 | 9,000 | 8 K to 9 K (+12.50 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.77 | 1,000 | 770 | 8,000 | 7 K to 8 K (+14.29 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.70 | 2,000 | 1,400 | 7,000 | 5 K to 7 K (+40.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.75 | 2,000 | 1,500 | 5,000 | 3 K to 5 K (+66.67 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.73 | 1,000 | 730 | 3,000 | 2 K to 3 K (+50.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.76 | 1,000 | 760 | 2,000 | 1,000 to 2 K (+100.00 %) |
| May 31 2017 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Buy | P | 0.77 | 1,000 | 770 | 1,000 | 0 to 1,000 |
| May 15 2017 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | P | 0.77 | 10,000 | 7,700 | 50,000 | 40 K to 50 K (+25.00 %) |